Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA)Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22026-01-02NCT04367311

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Genentech, Inc.221
Nasser Hanna1

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Indiana University Melvin and Bren Simon Cancer CenterIndianapolisUnited States17
New York University Clinical Cancer CenterNew YorkUnited States4
Northwestern University Feinberg School Of MedicineChicagoUnited States49
Ohio State University Comprehensive Cancer CenterColumbusUnited States548
Penn State Cancer InstituteHersheyUnited States17
Rutgers Cancer Institute of New JerseyNew BrunswickUnited States223
Summit HealthBerkeley HeightsUnited States1
University of Virginia Health SystemCharlottesvilleUnited States57
University of WisconsinMadisonUnited States64